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ABSTRACT: In this paper an attempt has been made to evaluate the theory of Ayurveda on 
rheumatoid arthritis, in relation to the modern medical concept.  The evolution of the disease, its 
etiopathogenesis, its pathological, biochemical as well as therapeutic data published in support 
of this concept and finally the details of clinical trial of Sunthi in treating 265 patients are dealt 
with. 
 
The rheumatic diseases especially 
rheumatoid arthritis have been causing 
immense suffering to the people throughout 
the world.  This state of affairs has been 
mainly due to lack of proper understanding 
of the disease process.  Intensive studies 
have put-forth several concepts of its 
etiopathogenesis.  Out of these the definite 
role of genetics and immunity has been 
established (Kishore 1965).  The exact 
mechanism and the beginning of the process 
is not still understood.  As such, efforts are 
being continued to study the 
etiopathogenesis of the disease.  In this 
context the ancient Indian concept of role of 
impaired gastrointestinal function 
(enteropathy) has also been taken up for 
investigation more than two decades ago 
(Kishore 1965).  It is interesting to note that 
the modern scientific workers in other parts 
of the world have also putforth certain 
similar theories of its causation (Shat in 
1964).  An attempt has been made in this 
paper to evaluate the theory of ancient 
Indian medicine – Ayurveda, in relation to 
the modern medical concept.  These may be 
broadly grouped into three.  The first dealing 
with the evolution of the disease, its 
etiopathogenesis, the second diseases, the 
pathological, Biochemical as well as 
therapeutic data published in support of this 
concept and finally the details of trials of 
Sunthi in series of 4 trials consisting of 265 
patients. 
 
Evolution: 
 
The antiquity of this disease may be traced 
from the very beginning of the civilization 
on the basis of findings on ancient Egyptian 
mummies.  Though its description in 
medical sciences was initiated by 
Hippocrates (6
th  century B. C.) the first 
clinical description of this disease was only 
put forth by Arteus (100 A D).  The term 
“Rheumatis” was coined by Galen (199 
A.D.) who also specified the “Arthritis” to 
indicate joint disease.  Further developments 
in understanding this disease could take 
place only after more than 1400 years, in the 
17
th  century further developments in 
understanding this could take place with the Pages 203 - 216 
 
identification of Gout from Rheumatism by 
de Baileu which was followed by further 
classification of Rheumatis into acute and 
chronic varieties (Sydenham 1629 – 89 A. 
D.)  the proper clinical description and 
present nomenclature was put forth only in 
the middle of last century.  Certain concepts 
of etiology indicating  its neurogenic and 
infective origin were also proposed during 
this century.  The intensive studies on 
sedimentation rate, hypersensivity/auto 
immunity and demonstration of 
“Rheumatoid factor” and its practice / such 
as the introduction of therapeutic criteria and 
functional tests in the evaluation of the 
effect of the treatment, practice of gold salt 
cortisone and ACTH therapy are some of the 
important achievements during the first half 
of this century.  Later, detailed studies on 
the diagnostic significance of rheumatoid 
factor contributed to development of more 
serological tests.  Since the problem of 
suitable diagnosis has still remained 
unsolved, the ARA developed certain 
criteria, on the basis of serological, 
radiological, biochemical, pathological and 
clinical findings on this disease.  Certain 
new therapeutic agents such as, 
Phenylbutozone, anti-malarials and 
indomethalicin were also introduced 
simultaneously.  The term intestinal arthritis 
was introduced subsequently along with the 
role of enteropathy in the etiopathogenesis 
and management of this disease. 
 
On the other hand, the description of this 
disease in Ayurveda dates back about 1000 
B.C. In the earlier period the joint diseases 
were discussed mainly under the title 
‘Vatarakta’.  The etiological factor i.e. 
‘Ama’ was said to produce various diseases 
in combination of various Dosas and Dusyas 
of the body.  The same trend continued up to 
6
th century A. D. where in the description of 
manifestations of Ama  was given and the 
diseases occurring due to Ama were termed 
as Sama. 
 
The terms Amavata has been mentioned in 
Charaka Samhita, which may date back to 
1000 B.C., possibly to denote the relation of 
Ama with Vata  as discussed earlier.  The 
Madhava Nidana (900 A.D) though 
compiled as an abstract treatise on clinical 
diagnosis, has included several new 
diseases.  Among these the diseases 
Amavata deals in detail the etiopathogenesis 
and manifestations of a disease entity in 
addition to the joint disease mentioned 
earlier, whose clinical manifestations are 
very much similar to Rheumatoid Arthritis.  
The basic etiological factor in this disease 
has been considered as impaired gastro – 
intestinal function.  The clinical features of 
the disease may be grouped broadly into 
three categories.  The general ones and those 
relating to pain and swelling of the joints 
and the sequelae or complications.  In all 
these aspects the symptoms largely reflect 
the inflammatory swelling of the joints and 
disturbed / impaired gastro –  intestinal 
function.  Following this description in 
various books on clinical diagnosis and 
therapy have devoted separate chapters for 
this disease.  The principles of treatment 
enunciated by Chakradutta  (1075 A. D.) 
lays great emphasis on  augmenting the 
functions of the gastro intestinal tract.    
Certain herbal and herbomineral 
preparations were added subsequently.  The 
relationship between gastro intestinal 
diseases  Amatisara  and  Grahanidosa  have 
been put forth by Harita Samhita  (12
th 
century) and Yogaratnakara (17
th century).  
Gananath Sen (1943) discussed joint 
diseases under Sandhivata Nidana and on of 
its five varieties was termed as Rasavata – 
rheumatoid arthritis.  Sudarsan Shastri 
(1953) considered rheumatoid arthritis as 
Amavata and rheumatic fever as one of the 
Sanipatika Jwara.   The concept of Sama Pages 203 - 216 
 
and  Nirama  stages in its treatment was 
introduced later (Shasri 1961). 
 
Etiopathogenesis 
 
The modern medical sciences have 
gradually recognized the Rheumatoid 
arthritis as a systemic disease.  Various 
theories regarding its etiopathogenesis such 
as neurogenic, vascular, infective, 
metabolic, endocrinal,auto-immune and 
psychogenic have peen put forth from time 
to time.  The familial proneness to this 
disease has clinched the important role of 
genetics in the etiopathogenesis of this 
disease.  Presently it is being considered as 
an auto immune disorder though endocrine, 
metabolic and infection factors are not 
completely ruled out.  In addition, a new 
proposition assigning crucial role of 
enteropathy has also been put forth.  The 
pathogenesis of this disease according to this 
concept revolves round the inherent 
susceptibility to enteropathy which can be 
activated by diet (gluten), trauma, infection 
and drugs acting on small intestine.  This 
enteropathy leads to the malaabsorption and 
impeded biosynthesis of protein resulting in 
excessive dissolution of collagen tissues.  
This process causes further damage to the 
intestine (Fig. I). 
 
 
 
With the perusal of Ayurvedic literature it is 
evident that there is ample emphasis, on the 
gastro  –  intestinal disturbances as the 
primary cause of rheumatoid arthritis 
(Amavata).  Hypo functioning of digestive 
mechanism as a whole is the sheet anchor 
which leads to incomplete processing of 
food.  An interesting theory has been 
advanced that some component of this 
incompletely proceed food –  Ama  is Pages 203 - 216 
 
absorbed in the system and is capable to 
produce vascular and tissue changes 
(Srotobhishyanda).  The involvement of 
Shleshaka Kapha   in the pathogenesis of 
Amavata has got great resemblance with that 
of connective tissue disorder.  The 
observation of Yoga Ratnakara in this 
reference about Grahani Dosa is also very 
pertinent.  The concept of Grahani Dosa is 
analogous to enteropathy, usually it initiates 
Grahani Roga (colic disease) but its relation 
with  Amavata  (Rheumatoid Arthritis) is 
another aspect of its clinical manifestation 
(Fig. 2). 
 
Thus the thought in the Indigenous system 
of medicine in connection with the causation 
of rheumatoid arthritis, is very much similar 
with the school of today considering gastro-
intestinal disorders to be primary; however, 
a few novelties are also there.  Shatin has 
explained the initiation of vascular and 
tissue changes in the target organs to be a 
passive phenomenon following 
hypoproteinemia as the result of 
malasbsorption.  On the other hand 
Ayurveda believes it to be an active 
phenomenon.  Ama  –  component of 
incompletely processed food reacts and 
interacts with the humours and cells of the 
body and finally initiates the vascular and 
tissue changes in the target organs.   
According to them various psychological, 
dietary and other factors only operate 
through the gastro-intestinal system leading 
to hypo functioning of digestive mechanism.  
The role of Ama  has a great resemblance 
with the theory of altered immune 
mechanism (Tripathy, Shukla and Kishore, 
1965).  Allergic manifestations with the 
absorption of denatured proteins from the 
intestinal tract is a known example of such a 
possibility.  The exacerbation in the gastro-
intestinal symptoms during active phase of 
the disease may also be explained with this 
hypothesis. 
 
In short according to Ayurveda the various 
etiological factors operate through the 
gastro-intestinal axis, leading to its hypo 
functioning and further damages.  Further 
the incompletely processed food Ama  - 
(having antigenic property) produces the 
disease following multiple changes in the 
body.  Thus the concepts of gastro – 
intestinal disorder specially enteropathy and 
altered immune mechanisms are interwoven 
together in this theory.  No doubt hypo – 
proteinemia, the result of enteropathy 
produces susceptibility to fibrinoid change, 
which may be precipitated by the action of 
Ama (Fig. 3).  
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Observation on Gastro – Intestinal Disfunction / Impairment 
 
Gastro  –  intestinal disfunction has been 
considered to be the cause of all diseases in 
Ayurveda.  Its role in various disease is 
explicitly discussed.   As already mentioned 
this concept has been very much emphasized 
in the etiopathogenesis of Amavata  – 
rheumatoid arthritis.  The observation of 
clinical manifestations indicating gastro  – 
intestinal disfunction such as anorexia, loss 
of appetite, constipation or diarrhoea have 
also been discussed in the text books of 
modern medicine.  (Traut 1952, Duthie 
1964).  In addition certain conditions like 
non specific ulcerative colitis and regional 
enteritis have also been reported to be 
associated with the causation, exacerbation 
and remission of rheumatoid arthritis.   
Certain studies have also indicated 
comparatively higher incidences of gastro – 
intestinal diseases in the patients of 
rheumatoid arthritis than the diseases of 
other system (Gibberd 1965). 
 
The biochemical and histopathological 
observations on stomach, liver and small 
intestine have also been reported from 
various countries, (Table – I) also definitely 
indicated impairment of function of these 
organs. 
 
TABLE – I 
 
Showing observation on impaired gastro – intestinal function 
 
A. Stomach 
 
 
 
 
 
 
 
 
B. Liver 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gaspordy & Vida (1964) 
 
 
Kirshore P. (1966) 
 
 
Pelika V. et al (1962) 
 
 
Morace G et al (1964) 
 
 
 
 
 
Panerai A et al (1964) 
 
 
 
 
Castenfors E et al (1964) 
 
 
Kishore P. (1964) 
Gastric acid showed 48% anacid and 
25% subacid in 200 patients of RA 
 
Gastric acid – Achlor in 5 cases and hypo 
in 5 cases among 28 cases of RA 
 
Histologically changes in gastric mucosa 
leading to atrophic gastritis 
 
Among 18 patients studies Thymol 
turbidity was pathologically increased in 
15 (83%) cases, serum prothrombin level 
decreased in 11 (71%) cases and B.S.C 
test was abnormal in 15 (83%) cases. 
 
Liver biopsies on 18 cases of RA showed 
infiltration, presence of mononuclear 
cells, proliferation of Kupfer’s cells and 
fatty degeneration. 
 
BSP test was abnormal in 21 cases out of 
22 cases of RA 
 
Thymol turbidity raised in more than Pages 203 - 216 
 
 
 
 
 
 
C. Small intestine 
 
 
 
 
 
 
 
 
 
 
 
Sievers K et al (1964) 
 
Kishore P (1964) 
 
 
 
 
 
Tripathy S. N. et al (1979) 
 
 
Sharma et al (1981) 
 
Tewari C met al (1979) 
 
 
 
 
80% of cases, alkaline phosphatase raised 
in more than 50% of cases. 
 
Parenchymal liver damage. 
 
Intestinal absorption – d – xylose below 
normal in more than 40% cases, radio-
iodinated human serum albumin 
absorption test indicates subnormal value 
in 2/3
rd of patients. 
 
d – xylose absorption below normal. 
 
 
d – xylose absorption below normal. 
 
d -  xylose below normal in all cases (10).  
Thyroid function lowered, shortening 
broadening and infiltration of the villi of 
the Jejunum. 
 
 
Clinical trial of sunthi preparation 
 
In order to study the effect of gastro-
intestinal stimulant drugs in the treatment of 
rheumatoid arthritis the present series of 
trials of Sunthi preparations have been taken 
up.  The drug Sunthi  –Zingiber officinal 
(dry) has been selected for trial since this 
has been extensively recommended as a 
single drug in simple combinations as well 
as in most of the compound formulations 
recommended in Ayurveda for the treatment 
of this disease.  The pharmacodynamic 
properties of Sunthi    are opposite to the 
properties of Rasa, Kapha and Ama, which 
are bodily factors (Dosa – Dushyas involved 
in the etiopathogenesis of this disease.  This 
drug has also shown therapeutic efficacy in 
the patients of Grahaniroga  (enteropathy, 
M. A. S.) (Dixit et al 1977) which has been 
said to be the basic pathology in the patients 
of Amavaa as well. 
 
The combinations for the trial, Sunthi  – 
Guduchi, Sunthi –  Guggulu and Rasonadi 
Kvatha (Rasona – Sunthi – Nirgundi) have 
been selected on the basis of their classical 
description as well as published data 
supporting their efficacy in the treatment of 
this disease.  In order to have the idea of its 
comparative efficacy a standard set of 
Ayurvedic preparation consisting of Yogaraj 
Guggulu, Vatagajankusha Rasa / Amavatrai 
Rasa, Maharasnadi Kvatha  has also been 
prescribed to control group of cases. 
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Materials and Methods 
 
The patients for trials were selected on the 
basis of ARA criteria (1959) and only 
clinical findings as morning stiffness, pain 
in motion, swelling of one joint, swelling of 
another joint, symmetrical involvement of 
joints sub-cutaneous nodules over bony 
prominences along with radiological reports 
were taken into account.  After admission 
the patients were subjected to detailed 
clinical examinations pertaining availability 
of relevant findings, their intensity as well as 
certain functional tests and measurement of 
joints.  Aspecific proforma evolved was 
filled up for each patient.  In some cases 
photographs of the affected joints were also 
taken. 
 
The following treatments in four separate 
trials were given groupwise as follows 
(Table 2). 
 
In addition to the above medicines, Baluka 
Sveda and Lepa were given in the acute 
stage of the disease. 
 
Assessment and Classification of Results. 
 
The assessment of the results has been done 
according to the changes in clinical findings.  
In addition, the changes in ESR test, 
functional tests and measurement of the 
joints have been noted.  The results of the 
treatment have been classified as follows: 
 
Complete relief:  Completely free from signs 
/ symptoms of joints inflammation with free  
 movement of the joints except those due to 
irreversible changes. 
 
Partial relief: Reduction of  signs / 
symptoms of the joint inflammation and 
improvement  of  joint                        
movement to a major extent, but not fully. 
 
No relief: No response at all or only 
marginal improvement of the condition. 
 
Drop out: The patients who discontinued the 
treatment before stipulated period. 
 
TABLE – II 
 
Trial No. 1 
 
 
 
 
 
Trial No. 2 
 
 
 
 
Trial No. 3 
 
Trial No. 4 
A. Yogaraj Guggulu – 1 gm 
Vatagajankusa Rasa – 250 mg. 
Maharasanadi Kvatha – 50 ml. 
B. Sunthi – Guduci Kvatha 25 ml. 
– 50 ml. 
 
A. Sunthi – Guggulu – 2 gms 
B. Yogaraja Guggulu – 2 gms 
     Amavatari Rasa – ½ gm 
     Maharasanadi Kvatha – 25 ml. 
 
Rasanadi Kvatha – 25 ml. 
 
Sunthi – Guggulu – 2gms 
 
 
Thrice daily 
 
 
Thrice daily 
 
 
Thrice daily 
Thrice daily 
 
 
 
Thrice daily 
 
Thrice daily 
40 patients 
 
 
37 patients 
 
 
36 patients 
27 patients 
 
 
 
50 patients 
 
75 patients Pages 203 - 216 
 
Observations 
 
The observations on 265 patients in four 
separate trials have been taken up for a 
period of more than six years to assess the 
role of Sunthi and certain other drugs in the 
treatment of rheumatoid arthritis.  The 
observations on the general clinical profile 
of patients have been discussed first and the 
effect of each combination of Sunthi  in 
different trials have been discussed 
separately. 
 
The general clinical profile 
 
The observations indicated that the disease 
affects the individuals of either sex in all age 
groups, though the incidence appears to be 
maximum in the age group of 21 – 30 years 
(Table – III), (Figure – 4). 
 
The patients have been suffering with the 
disease  mostly from less than one year 
duration, though many chronic patients 
suffering for the duration of more than 10 
years were also observed.  The knee joints, 
ankle joints and wrist joints were most 
commonly affected (Figure –  5).  Certain 
patients, where X- ray of joints were taken, 
showed varying degree of changes ranging 
from Osteoporosis to Anklyosis and fusion 
of bones.  The overall classification of cases 
taken up for trial as per the ARA criteria has 
been observed as either “Definite or 
Classical”.  The joint involvement are 
invariably poly – articular and symmetrical.  
The ESR has been found to be raised in 
most of the patients.  Though most of the 
patients were having Gastro –  intestinal 
symptoms such as constipation, loss of 
appetite etc. certain patients with  chronic 
diarrhoea were also observed.  It was also 
noted that the intensity of the disease was 
directly related to the intensity of the 
diarrhoea. 
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TABLE – III 
 
Showing the age and sex 
 
Sex 
Age in years 
Total 
1 – 10  11 – 20  21 – 30  31 – 40  41 – 50  51 – 60  61 and 
above 
Male 
 
Female 
 
4 
 
2 
34 
 
22 
49 
 
25 
18 
 
24 
16 
 
22 
17 
 
14 
7 
 
11 
145 
 
120 
 
Total 
 
 
6 
 
56 
 
74 
 
42 
 
38 
 
31 
 
18 
 
265 
 
Therapeutic efficacy: 
 
(i) SUNTHI – GUDUCI  
 
The trial of a 12 weeks course of Sunthi – 
Guduci in the form of decoction in the dose 
of 25 –  50 ml. three times a day, in 
comparison to a combination of Yogaraja 
Guggulu, Vaagajankusa Rasa and 
Maharasnadi Kvatha has been taken up in 
77 patients in two groups.  The treatment 
gradually showed improvement in the pain, 
swelling and restriction of movement, the 
cardinal manifestation of the disease in both 
the groups of treatment.  The effect of 
Sunthi – Guduchi  has been relatively better 
since the percentage of patients with no 
relief and drop out has been much less than 
the other set of the treatment and many more 
patients have been reported partial Relief 
(Table – 4), (Figure – 5). 
 
The ESR have also shown significant 
reduction in the patients treated with Sunthi 
–  Guduci  and in most of the cases it has 
come within normal limits after treatment. 
 
(ii) SUNTHI – GUGGULU (A) 
 
A clinical trial of Sunthi  –  Guggulu  in 
comparision to Yogaraja Guggulu, 
Amavatari Rasa and  Maharasandi Kvatha 
has been taken up on 63 patients in two 
groups.  36 patients were treated with a six 
week course of Sunthi – Guggulu in the dose 
of 2 gms. Three times a day whereas the 2
nd 
group of 27 patients were treated with the 
other combination mentioned above.   
Remarakable improvement was observed 
within a short period of treatment with 
Sunthi  –  Guggulu  and the percentage of 
patients who reported complete relief and 
partial relief have been much more with the 
treatment by Sunthi  –  Guggulu  than the 
other combination mentioned above (Table 
– 5), (Figure – 7). Pages 203 - 216 
 
 
(iii) SUNTHI – GUGGULU (B) 
 
Keeping in view the better efficacy of Sunthi 
–  Guggulu  combination, efforts have been 
made to further assess its effect in a larger 
series of patients.  As such the trial of a six 
week course of Sunthi – Guggulu alongwith 
local external treatments have been taken up 
on 75 patients.  The effect of the drugs have 
been quite significant and it has been 
observed that almost all the cases who have 
completed the course have  shown definite 
improvement though, complete relief was 
observed in a small proportion of cases.   
Partial relief i.e. more than 50% were 
observed in 42 cases (Figure – 8).  It was an 
important observation that the patients in the 
early stage of diseases in younger age 
groups and the males showed better result of 
the treatment (Table – 6). Pages 203 - 216 
 
 
TABLE – IV 
 
Showing the results 
 
Results  Yogaraja Guggulu 
Vatagajankusa Rasa 
Maharasanadi 
Kvatha 
Sunthi – Guduci  Total 
Complete Relief 
 
Partial Relief 
 
No Relief 
 
Drop Out 
 
11 (27.5%) 
 
10 (25%) 
 
5 (12.5%) 
 
14 (35%) 
10 (27.2%) 
 
15 (40.54%) 
 
2 (5.40%) 
 
10 (27.02%) 
21 (21.2%) 
 
25 (32.46%) 
 
7 (9.9%) 
 
24 (31.16%) 
 
Total 
 
 
40 
 
37 
 
77 
 
 
TABLE – V 
 
Showing the results 
 
Results  Yogaraja Guggulu 
Amavatari Rasa 
Maharasanadi 
Kvatha 
Sunthi – Guduci  Total 
Complete Relief 
 
Partial Relief 
 
No Relief 
 
Drop Out 
 
8 (27.62%) 
 
6 (22.22%) 
 
-- 
 
13 (48.14%) 
12 (33.3%) 
 
12 (33.3%) 
 
-- 
 
12 (33.3%) 
20 (31.74%) 
 
18(28.57%) 
 
- 
 
25 (39.68%) 
 
Total 
 
 
27 
 
36 
 
63 
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(iv)  RASONADI KVATHA 
 
A Clinical trial of six week course of 
Rasanadi Kvatha  combination of Rasana, 
Sunthi and Nirgundi has been taken up on 50 
patients.  The treatment showed good effect 
since most of the patients who completed 
full course of treatment showed definite 
improvement  –  28% Complete relief and 
46% Partial relief.  It was observed that the 
drug was more effective in female patients 
(Table – 7), (Figure – 9). 
 
 
 
 
 
TABLE VII 
Showing the Results 
 
S.No.  Results  Male  Female  Total 
1 
 
2 
 
3 
 
4 
 
Complete Relief 
 
Partial Relief 
 
No Relief 
 
Drop Out 
5 (19.23%) 
 
12 (46.1%) 
 
2 (7.69%) 
 
7 (26.92%) 
9 (37.5%) 
 
11 (45.83%) 
 
1 (4.16%) 
 
3 (12.5%) 
14 
 
23 
 
3 
 
10 
Total  26  24  50 Pages 203 - 216 
 
DISCUSSION 
 
The impaired gastro – intestinal function has 
been said to play the crucial role in the 
etiopathogenesis of Rheumatoid arthritis in 
Ayurveda.  As already mentioned, this view 
has been further substained by the 
observations on gastro – intestinal functions 
such as acid secretion from stomach, liver 
function and intestinal absorption and 
histopathological studies on the mucosa of 
small intestine.  The therapeutic 
observations on Bhallataka  preparations 
have also  further confirmed this view 
(Kishore 1965, Tripathy et al 1979, Sharma 
et al 1981).  Similar view on gastro – 
intestinal disfunction – entropathy has also 
been assigned etiological role by some 
modern scientific workers in recent past. 
 
 
 
In view of the Ayurvedic concept of Gastro 
–  intestinal etiology of this disease an 
attempt has been made to assess the effect of 
Sunthi in the treatment of this disease.  This 
drug has been said to regulate the bowel 
movement by way of controlling loose and 
watery motion as well as relieving 
constipation.  The digestive / stimulant 
action of the drug has been well established.  
Thus, this drug will be able to alleviate the 
‘Ama’  the  chief causative agent of the 
disease according to Ayurveda.  This 
concept has been put to test on a series of 
four trials with the various combinations of 
Sunthi as a major ingredient.  The effect of 
its combination has been better than that of 
the prevent Ayurvedic preparations such as 
Yogaraja Guggulu, Vatagajangusa Rasa, 
Amavatari Rasa and Maharasandi Kvatha.   
The effect of the combination of Sunthi may 
be attributed primarily to its effects on 
gastro-intestinal tract, and it being a major 
ingredient in all these combinations as well 
as sufficient dose.  According to Ayurvedic 
Pharmaco dynamic principles the drug 
Sunthi  possesses ‘Katurasa’ that is 
combination of Agni and Vayu Mahabhutas 
(Sharma Acarya Priyavrata – 1976) since the Pages 203 - 216 
 
properties available in the drugs also exist in 
the human body (Susruta), when ingested, it 
enhances the strength of Agni  due to 
similarity.  So the ‘Dhatvagnis’  and 
Bhutagnsi  nourished by Panchakagni 
(Charak) act in a proper manner throughout 
the body including ‘Srotas’  to convert the 
‘Ama’  already produced and to prevent its 
production.  When major features of this 
disease like inflammation and morning 
stiffness are said to be due to accumulation 
of oedema fluid within inflamed tissues, it is 
supposed to remove this due to its 
‘Dravasosaka’ action.  Further it alleviates 
‘Kapha’    due to its properties like ‘Usna’ 
‘Tiksna’, and ‘Usnavirya’ as well as ‘Vata’ 
due to its ‘Madhura Vipaka’, these two take 
dominant role in pathogenesis of this 
disease.  The efforts to evaluate a potent 
Ayurvedic gastro –  intestinal drug in the 
treatment of rheumatoid arthritis has 
indicated that the treatment acts on the 
process of etiopathogenesis of this disease 
and prevents / alleviates the formation of 
‘Ama’.  These observations further confirm 
the Ayurvedic concept of gastro – intestinal 
origin of the disease by providing further 
therapeutic evidence. 
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